
Cepheid
Total Raised
$60.7MInvestors Count
13Deal Terms
3Funding, Valuation & Revenue
8 Fundings
Cepheid has raised $60.7M over 8 rounds.
Cepheid's latest funding round was a Grant for $28M on July 30, 2021.
Cepheid's valuation in November 2016 was $4,000M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/30/2021 | Grant | $28M | U.S. Department of Health and Human Services | 1 | ||
11/5/2016 | Acq - P2P | $4,000M | ||||
6/21/2000 | IPO | |||||
1/6/2000 | Series C | |||||
10/1/1998 | Series A |
Date | 7/30/2021 | 11/5/2016 | 6/21/2000 | 1/6/2000 | 10/1/1998 |
|---|---|---|---|---|---|
Round | Grant | Acq - P2P | IPO | Series C | Series A |
Amount | $28M | ||||
Investors | U.S. Department of Health and Human Services | ||||
Valuation | $4,000M | ||||
Revenue | |||||
Sources | 1 |
Cepheid Deal Terms
3 Deal Terms
Cepheid's deal structure is available for 3 funding rounds, including their Acq - P2P from November 05, 2016.
Round | Acq - P2P | Series A | Series B |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
Series A | |||||||||||||||
Series B |
Cepheid Investors
13 Investors
Cepheid has 13 investors. U.S. Department of Health and Human Services invested in Cepheid's Grant funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/30/2021 | 7/30/2021 | U.S. Department of Health and Human Services | 1 Grant | Government | DC | |
11/5/2016 | 11/5/2016 | 1 Acq - P2P | Corporation | DC | ||
4/13/1998 | 1/6/2000 | 2 Series B, Series C (2000) | Investment Bank | New York | ||
Corporation | Minnesota | |||||
Investment Bank | Georgia |
First funding | 7/30/2021 | 11/5/2016 | 4/13/1998 | ||
|---|---|---|---|---|---|
Last Funding | 7/30/2021 | 11/5/2016 | 1/6/2000 | ||
Investor | U.S. Department of Health and Human Services | ||||
Rounds | 1 Grant | 1 Acq - P2P | 2 Series B, Series C (2000) | ||
Board Seats | |||||
Type | Government | Corporation | Investment Bank | Corporation | Investment Bank |
Location | DC | DC | New York | Minnesota | Georgia |
Cepheid Acquisitions
2 Acquisitions
Cepheid acquired 2 companies. Their latest acquisition was OncoMark on December 16, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/16/2021 | Other | $9.9M | Acquired | 4 | ||
10/3/2014 |
Date | 12/16/2021 | 10/3/2014 |
|---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | $9.9M | |
Note | Acquired | |
Sources | 4 |
Compare Cepheid to Competitors

Genalyte is a tech-enabled laboratory that specializes in rapid onsite lab testing and automation within the healthcare sector. The laboratory offers comprehensive lab services with results in less than 30 minutes, utilizing a mobile laboratory platform and a central lab for tests that cannot be performed onsite. Genalyte primarily serves the healthcare industry with its College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified lab services, facilitated by its proprietary CloudLab telehealth platform and the Maverick platform for serological testing. It was founded in 2007 and is based in San Diego, California.

Biomeme focuses on DNA diagnostics and disease surveillance in healthcare and research. The company provides a platform that allows smartphones to analyze and identify pathogens and diseases based on their DNA or RNA signatures. Biomeme serves the healthcare, agriculture, environmental, veterinary, and educational sectors with mobile testing solutions. It was founded in 2012 and is based in Philadelphia, Pennsylvania.

Ethicon operating as a subsidiary of Johnson & Johnson, focuses on advancing surgical care. The company's main offerings include surgical technologies and solutions such as sutures, staplers, energy devices, and digital solutions. It aims to improve and save lives through innovative medical procedures. Ethicon primarily serves the healthcare industry. It was founded in 2010 and is based in Warsaw, Indiana.

Ascensia Diabetes Care operates as a global company focused on diabetes care within the healthcare industry. The company offers a range of products including blood glucose monitoring systems and continuous glucose monitoring systems to help individuals with diabetes manage condition. It was founded in 2016 and is based in Basel, Switzerland.

Meridian is a life science company involved in the development, manufacturing, marketing, and distribution of diagnostic test kits and reagents. The company provides diagnostic products that are used outside the human body with minimal equipment requirements for the diagnosis of medical conditions such as infections and lead poisoning. Meridian serves hospitals, reference laboratories, research centers, diagnostics manufacturers, and agri-bio companies globally. It was founded in 1977 and is based in Cincinnati, Ohio.
Meterbolic conducts metabolic health assessments and preventive healthcare within the medical diagnostics sector. The company offers tests that measure insulin response and other metabolic markers to predict the risk of diabetes and other chronic diseases, which can assist in health management. Meterbolic serves individuals seeking health monitoring and those interested in preventive healthcare. It was founded in 2018 and is based in London, United Kingdom.
Loading...

